Patient-Derived Tumor Organoid Drug Development Platform Launched

SAN DIEGO, Oct. 17 (Korea Bizwire) — Crown Bioscience today announced the launch of a new tumor organoid drug development platform with the potential to significantly improve the predictivity and speed of preclinical drug discovery. The initial phase of the platform launch features the first commercially available 3D in vitro PDX-derived organoid (PDXO) models generated from CrownBio’s [...]